|
1.
|
|
12 p, 266.2 KB |
Quality markers in cardiology : Measures of outcomes and clinical practice - A perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular Surgery
/
López-Sendón, José-Luis (Hospital Universitario La Paz (Madrid)) ;
González-Juanatey, José Ramón (Hospital Universitario La Paz (Madrid)) ;
Pinto, Fausto (Hospital Universitario La Paz (Madrid)) ;
Castillo, José Cuenca (Hospital Universitario La Paz (Madrid)) ;
Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ;
Dalmau, Regina (Hospital Universitario La Paz (Madrid)) ;
Torrecilla, Esteban González (Hospital Universitario La Paz (Madrid)) ;
Mínguez, José Ramón López (Hospital Universitario La Paz (Madrid)) ;
Maceira, Alicia M (Hospital Universitario La Paz (Madrid)) ;
Pascual-Figal, Domingo (Hospital Universitario La Paz (Madrid)) ;
Pomar Moya-Prats, José Luis (Hospital Universitario La Paz (Madrid)) ;
Sionis, Alessandro (Hospital Universitario La Paz (Madrid)) ;
Zamorano, José Luis (Hospital Universitario La Paz (Madrid)) ;
Universitat Autònoma de Barcelona
2016 -  10.1093/eurheartj/ehv527
European heart journal, Vol. 37 Núm. 1 (january 2016) , p. 12-23
|
|
|
2.
|
|
9 p, 627.4 KB |
Effects of alirocumab on types of myocardial infarction : Insights from the ODYSSEY OUTCOMES trial
/
White, Harvey D. (Auckland City Hospital) ;
Gabriel Steg, P. (Royal Brompton Hospital (Londres)) ;
Szarek, Michael (SUNY Downstate Medical Center School of Public Health) ;
Bhatt, Deepak L (Harvard Medical School) ;
Bittner, Vera A. (University of Alabama at Birmingham) ;
Diaz, Rafael (Instituto Cardiovascular de Rosario) ;
Edelberg, Jay M. (Sanofi) ;
Erglis, Andrejs (University of Latvia) ;
Goodman, Shaun G. (University of Toronto) ;
Hanotin, Corinne (Sanofi) ;
Harrington, Robert A. (Department of Medicine) ;
Wouter Jukema, J. (Leiden University Medical Center) ;
Lopes, Renato D. (Duke Clinical Research Institute) ;
Mahaffey, Kenneth W. (Stanford University School of Medicine) ;
Moryusef, Angele (Sanofi) ;
Pordy, Robert (Regeneron Pharmaceuticals) ;
Roe, Matthew T. (Duke Clinical Research Institute) ;
Sritara, Piyamitr (Mahidol University) ;
Tricoci, Pierluigi (CSL Behring) ;
Zeiher, Andreas Michael (Goethe University) ;
Schwartz, Gregory G. (University of Colorado School of Medicine) ;
Cequier Fillat, Angel R. (hospital Universitari de Bellvitge) ;
Garcia-Dorado, David (Hospital Universitari Vall d'Hebron) ;
Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ;
Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Coca Payeras, Antoni (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4, related to percutaneous coronary intervention; and Type 5, related to coronary artery bypass surgery. [...]
2019 - 10.1093/eurheartj/ehz299
European heart journal, Vol. 40 Núm. 33 (january 2019) , p. 2801-2809
|
|
|
3.
|
|
10 p, 701.1 KB |
Circulating non-coding RNAs in biomarker-guided cardiovascular therapy : A novel tool for personalized medicine?
/
Gonzalo Calvo, David de (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Vea, Ángela (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Bär, C. (Hannover Medical School) ;
Fiedler, J. (Hannover Medical School) ;
Couch, L.S. (Imperial College London) ;
Brotons, Carlos (Institut d'Investigació Biomèdica Sant Pau) ;
Llorente-Cortes, Vicenta (Institut d'Investigació Biomèdica Sant Pau) ;
Thum, T. (Hannover Medical School) ;
Universitat Autònoma de Barcelona
Current clinical guidelines emphasize the unmet need for technological innovations to guide physician decision-making and to transit from conventional care to personalized cardiovascular medicine. Biomarker-guided cardiovascular therapy represents an interesting approach to inform tailored treatment selection and monitor ongoing efficacy. [...]
2019 - 10.1093/eurheartj/ehy234
European heart journal, Vol. 40 Núm. 20 (january 2019) , p. 1643-1650
|
|
|
4.
|
|
12 p, 1.5 MB |
The valve uptake index : improving assessment of prosthetic valve endocarditis and updating [ 18 F]FDG PET/CT(A) imaging criteria
/
Roque, Albert (Hospital Universitari Vall d'Hebron) ;
Pizzi, María N (Hospital Universitari Vall d'Hebron) ;
Fernández-Hidalgo, Nuria (Hospital Universitari Vall d'Hebron) ;
Romero-Farina, Guillermo (Hospital Universitari Vall d'Hebron) ;
Burcet, Gemma (Hospital Universitari Vall d'Hebron) ;
Reyes-Juarez, José Luis (Hospital Universitari Vall d'Hebron) ;
Espinet, Carina (Hospital Universitari Vall d'Hebron) ;
Castell-Conesa, Joan (Hospital Universitari Vall d'Hebron) ;
Escobar, Manuel (Hospital Universitari Vall d'Hebron) ;
Ferreira-Gonzalez, Ignacio (Hospital Universitari Vall d'Hebron) ;
Aguadé-Bruix, Santiago (Hospital Universitari Vall d'Hebron) ;
Cuellar-Calabria, Hug (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Diagnosis of prosthetic valve endocarditis (PVE) by positron emission computed tomography angiography (PET/CTA) is based on visual and quantitative morpho-metabolic features. However, the fluorodeoxyglucose (FDG) uptake pattern can be sometimes visually unclear and susceptible to subjectivity. [...]
2022 - 10.1093/ehjci/jeab279
European Heart Journal Cardiovascular Imaging, Vol. 23 (january 2022) , p. 1260-1271
|
|
|
5.
|
|
10 p, 536.2 KB |
Prevention of stroke in patients with chronic coronary syndromes or peripheral arterial disease
/
Parker, W.A.E. (University of Sheffield) ;
Gorog, D.A. (University of Hertfordshire) ;
Geisler, T. (University of Tübingen) ;
Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Sibbing, D. (Medizinische Klinik und Poliklinik I. Campus Großhadern) ;
Rocca, B. (Catholic University) ;
Storey, R.F. (University of Sheffield) ;
Universitat Autònoma de Barcelona
Stroke is a common and devastating condition caused by atherothrombosis, thromboembolism, or haemorrhage. Patients with chronic coronary syndromes (CCS) or peripheral artery disease (PAD) are at increased risk of stroke because of shared pathophysiological mechanisms and risk-factor profiles. [...]
2021 - 10.1093/EURHEARTJ/SUAA165
European heart journal supplements, Vol. 22 (2021) , p. M26-M34
|
|
|
6.
|
|
6 p, 940.5 KB |
A different type of acute myocarditis : A case report of acute autoimmune myocarditis mediated by anti-PD-1 T lymphocyte receptor (pembrolizumab)
/
Salido Iniesta, Mario (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
López López, Laura (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Carreras Costa, Francesc (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Pembrolizumab is an immune check-point inhibitor (ICI), which acts by blocking the T lymphocyte PD-1 inhibitor receptor. It has been increasingly used in advanced or non-responsive tumours with promising results. [...]
2020 - 10.1093/EHJCR/YTAA214
European heart journal. Case reports, Vol. 4 Núm. 5 (2020) , p. 1-6
|
|
|
7.
|
|
13 p, 423.1 KB |
Pharmacological cancer treatment and venous thromboembolism risk
/
Muñoz Martín, A.J. (Hospital General Universitario Gregorio Marañón) ;
Ramírez, S.P. (Hospital General Universitario Gregorio Marañón) ;
Morán, L.O. (Hospital General Universitario Gregorio Marañón) ;
Zamorano, M.R. (Universidad Complutense de Madrid) ;
Benéitez, M.C.V. (Universidad Complutense de Madrid) ;
Salcedo, I.A. (Hospital General Universitario Gregorio Marañón) ;
Escobar, I.G. (Hospital General Universitario de Ciudad Real) ;
Soria Fernández, José Manuel (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Risk factors for cancer-associated thrombosis are commonly divided into three categories: patient-, cancer-, and treatment-related factors. Currently, different types of drugs are used in cancer treatment. [...]
2020 - 10.1093/EURHEARTJ/SUAA004
European heart journal supplements, Vol. 22 (2020) , p. C2-C14
|
|
|
8.
|
|
23 p, 1.2 MB |
Circulating heart failure biomarkers beyond natriuretic peptides : review from the Biomarker Study Group of the Heart Failure Association (), European Society of Cardiology ()
/
Meijers, Wouter C. (University Medical Center Groningen, The Netherlands) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Mebazaa, Alexandre (Université de Paris) ;
Bauersachs, Johann (Hannover Medical School, Germany) ;
Cleland, John G.F. (University of Glasgow) ;
Coats, Andrew J. S. (University of Warwick, Coventry, UK) ;
Januzzi, James L. (Massachusetts General Hospital, Boston, USA) ;
Maisel, Alan S. (University of California, USA) ;
McDonald, Kenneth (St Vincent's University Hospital, Dublin, Ireland) ;
Mueller, Thomas (Hospital of Bolzano, Italy) ;
Richards, A. Mark (National University of Singapore) ;
Seferovic, Petar (Belgrade University, Serbia) ;
Mueller, Christian (University of Basel, Switzerland) ;
de Boer, Rudolf A. (University Medical Center Groningen, The Netherlands) ;
Universitat Autònoma de Barcelona
New biomarkers are being evaluated for their ability to advance the management of patients with heart failure. Despite a large pool of interesting candidate biomarkers, besides natriuretic peptides virtually none have succeeded in being applied into the clinical setting. [...]
2021 - 10.1002/ejhf.2346
European Journal of Heart Failure, Vol. 23 (october 2021) , p. 1610-1632
|
|
|
9.
|
|
5 p, 420.5 KB |
Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers : The EVO-HF trial
/
Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Lupón, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Revuelta-López, Elena (Institut Germans Trias i Pujol) ;
Llibre, Cinta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gastelurrutia, Paloma (Institut Germans Trias i Pujol) ;
Domingo, Mar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Codina, Pau (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santiago Vacas, Evelyn (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rangel-Sousa, Diego (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Fernández-Cisnal, Agustín (Fundación Investigación Clínico de Valencia-Instituto de Investigación Sanitaria) ;
Miñana, Gema (Universitat de València. Departament de Medicina) ;
Mollar, Anna (Fundación Investigación Clínico de Valencia-Instituto de Investigación Sanitaria) ;
Núñez, Julio (Universitat de València. Departament de Medicina)
Aim: Patients with heart failure with reduced ejection fraction (HFrEF) have not been shown to benefit from statins. We hypothesized that, by limiting disease progression in stable HFrEF of ischaemic etiology, the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor evolocumab could reduce circulating troponin levels, a surrogate biomarker of myocyte injury and atherosclerosis progression. [...]
2023 - 10.1002/ejhf.2932
European Journal of Heart Failure, Vol. 25 Núm. 8 (august 2023) , p. 1439-1443
|
|
|
10.
|
|
12 p, 16.7 MB |
Practical outpatient management of worsening chronic heart failure
/
Girerd, Nicolas (Université de Lorraine) ;
Mewton, Nathan (University Claude Bernard Lyon) ;
Tartière, Jean-Michel (Hôpital Sainte-Musse) ;
Guijarro, Damien (Université de Nantes) ;
Jourdain, Patrick (Assistance Publique-Hôpitaux de Paris) ;
Damy, Thibaud (CHU d'Henri-Mondor) ;
Lamblin, Nicolas (Université de Lille) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pellicori, Pierpaolo (University of Glasgow) ;
Januzzi, James L. (Harvard Medical School) ;
Rossignol, Patrick (Université de Lorraine) ;
Roubille, François (CHU de Montpellier) ;
Universitat Autònoma de Barcelona
Management of worsening heart failure (WHF) has traditionally been hospital-based, but with the rising burden of heart failure (HF), the pressure on healthcare systems exerted by this disease necessitates a different strategy than long (and costly) hospital stays. [...]
2022 - 10.1002/ejhf.2503
European Journal of Heart Failure, Vol. 24 (april 2022) , p. 750-761
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
